Hepatic GLP-1 receptor expression is markedly reduced in NAFLD patients and high-fat diet-fed animals, but butyrate supplementation increases the expression of the GLP-1 receptor and further reduces liver steatosis [67,68]. This evidence concerns the gene GLP1R and metabolic dysfunction-associated steatotic liver disease.